Brian Kneafsey Sells 25,000 Shares of Blend Labs (NYSE:BLND) Stock

Blend Labs, Inc. (NYSE:BLND) insider Brian Kneafsey sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $2.87, for a total value of $71,750.00. Following the completion of the sale, the insider directly owned 696,598 shares of the company’s stock, valued at $1,999,236.26. The trade was a 3.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Brian Kneafsey also recently made the following trade(s):

• On Tuesday, July 15th, Brian Kneafsey sold 25,000 shares of Blend Labs stock. The shares were sold at an average price of $3.63, for a total value of $90,750.00.
• On Monday, July 14th, Brian Kneafsey sold 20,000 shares of Blend Labs stock. The shares were sold at an average price of $3.42, for a total value of $68,400.00.
• On Monday, July 7th, Brian Kneafsey sold 20,000 shares of Blend Labs stock. The shares were sold at an average price of $3.46, for a total value of $69,200.00.
• On Monday, June 30th, Brian Kneafsey sold 20,000 shares of Blend Labs stock. The shares were sold at an average price of $3.31, for a total transaction of $66,200.00.
• On Monday, June 23rd, Brian Kneafsey sold 20,000 shares of Blend Labs stock. The shares were sold at an average price of $3.17, for a total transaction of $63,400.00.

Blend Labs Trading Down 0.8%

Shares of NYSE:BLND opened at $2.9850 on Thursday. The company has a market capitalization of $775.09 million, a price-to-earnings ratio of -19.90 and a beta of 1.24. Blend Labs, Inc. has a 12 month low of $2.63 and a 12 month high of $5.53. The firm’s 50-day moving average is $3.34 and its 200 day moving average is $3.44.

Blend Labs (NYSE:BLND) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.05). The company had revenue of $31.52 million during the quarter, compared to analysts’ expectations of $31.93 million. Blend Labs has set its Q3 2025 guidance at EPS. As a group, equities analysts forecast that Blend Labs, Inc. will post -0.19 EPS for the current fiscal year.

Institutional Investors Weigh In On Blend Labs

Several large investors have recently modified their holdings of BLND. Lightspeed Management Company L.L.C. purchased a new stake in shares of Blend Labs in the 4th quarter worth approximately $97,366,000. Vanguard Group Inc. lifted its position in shares of Blend Labs by 4.6% in the 1st quarter. Vanguard Group Inc. now owns 17,586,601 shares of the company’s stock worth $58,915,000 after purchasing an additional 775,091 shares during the period. Metavasi Capital LP lifted its position in shares of Blend Labs by 15.6% in the 1st quarter. Metavasi Capital LP now owns 5,554,101 shares of the company’s stock worth $18,606,000 after purchasing an additional 750,000 shares during the period. Whitebark Investors LP increased its holdings in shares of Blend Labs by 4.6% in the 2nd quarter. Whitebark Investors LP now owns 4,853,883 shares of the company’s stock valued at $16,018,000 after acquiring an additional 214,609 shares during the period. Finally, EdgePoint Investment Group Inc. increased its holdings in shares of Blend Labs by 28.2% in the 1st quarter. EdgePoint Investment Group Inc. now owns 3,318,924 shares of the company’s stock valued at $11,118,000 after acquiring an additional 729,512 shares during the period. Institutional investors own 52.56% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. JMP Securities reiterated a “market outperform” rating and set a $7.00 target price on shares of Blend Labs in a research report on Wednesday, May 28th. Wall Street Zen upgraded Blend Labs from a “sell” rating to a “hold” rating in a research report on Sunday. UBS Group decreased their target price on Blend Labs from $4.00 to $3.50 and set a “neutral” rating for the company in a research report on Friday, August 8th. Canaccord Genuity Group reiterated a “buy” rating and set a $5.25 target price on shares of Blend Labs in a research report on Monday, May 12th. Finally, The Goldman Sachs Group decreased their target price on Blend Labs from $5.60 to $4.80 and set a “buy” rating for the company in a research report on Monday, May 12th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $4.88.

About Blend Labs

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.